Overview
- Moderna told Handelsblatt on Wednesday that it is exploring the takeover of several Biontech production sites in Germany that Biontech plans to close.
- The company said it would only invest if Germany provides clearer framework rules and planning security similar to deals Moderna has struck with the UK and Canada.
- Moderna said it prefers acquiring existing factories to building new ones and would plan to keep staff on site if it moved forward with an investment.
- Biontech announced in early May that it will close multiple German sites, a step that could put up to 1,860 jobs at risk and opened the door to suitors such as Moderna.
- Moderna warned that losing local mRNA capacity would harm Europe’s technological sovereignty and pointed to growing mRNA activity in China as a strategic concern for policymakers.